Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Use of Bombyx mori silk fibroin in tissue engineering: From cocoons to medical devices, challenges, and future perspectives
A Bucciarelli, A Motta - Biomaterials Advances, 2022 - Elsevier
Silk fibroin has become a prominent material in tissue engineering (TE) over the last 20
years with almost 10,000 published works spanning in all the TE applications, from skeleton …
years with almost 10,000 published works spanning in all the TE applications, from skeleton …
Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine
M Hemshekhar, RM Thushara… - International Journal of …, 2016 - Elsevier
Hyaluronic acid (HA), is a glycosaminoglycan comprised of repeating disaccharide units of
N-acetyl-d-glucosamine and d-glucuronic acid. HA is synthesized by hyaluronan synthases …
N-acetyl-d-glucosamine and d-glucuronic acid. HA is synthesized by hyaluronan synthases …
Enzymatically crosslinked silk-hyaluronic acid hydrogels
In this study, silk fibroin and hyaluronic acid (HA) were enzymatically crosslinked to form
biocompatible composite hydrogels with tunable mechanical properties similar to that of …
biocompatible composite hydrogels with tunable mechanical properties similar to that of …
Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction
Cardiac cell therapy suffers from limitations related to poor engraftment and significant cell
death after transplantation. In this regard, ex vivo tissue engineering is a tool that has been …
death after transplantation. In this regard, ex vivo tissue engineering is a tool that has been …
A patch of detachable hybrid microneedle depot for localized delivery of mesenchymal stem cells in regeneration therapy
Mesenchymal stem cells (MSCs) have been widely used for regenerative therapy. In most
current clinical applications, MSCs are delivered by injection but face significant issues with …
current clinical applications, MSCs are delivered by injection but face significant issues with …
Natural biomaterials for cardiac tissue engineering: a highly biocompatible solution
Cardiovascular diseases (CVD) constitute a major fraction of the current major global
diseases and lead to about 30% of the deaths, ie, 17.9 million deaths per year. CVD include …
diseases and lead to about 30% of the deaths, ie, 17.9 million deaths per year. CVD include …
Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond
Cell-based therapy is emerging as a promising strategy for treating a wide range of human
diseases, such as diabetes, blood disorders, acute liver failure, spinal cord injury, and …
diseases, such as diabetes, blood disorders, acute liver failure, spinal cord injury, and …
Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015)
Mesenchymal stem cells have been used for cardiovascular regenerative therapy for
decades. These cells have been established as one of the potential therapeutic agents …
decades. These cells have been established as one of the potential therapeutic agents …
Can we engineer a human cardiac patch for therapy?
Some of the most significant leaps in the history of modern civilization—the development of
article in China, the steam engine, which led to the European industrial revolution, and the …
article in China, the steam engine, which led to the European industrial revolution, and the …
A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering
A three-dimensional scaffold composed of self-assembled polycaprolactone (PCL)
sandwiched in a gelatin–chitosan hydrogel was developed for use as a biodegradable …
sandwiched in a gelatin–chitosan hydrogel was developed for use as a biodegradable …